| SMMT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SMMT shares outstanding history going back to 11/11/2020:
Also see: SMMT Market Cap History SMMT YTD Return |
SMMT Shares Outstanding History — Summit Therapeutics Share Count Over Time
As of 7/17/2026 Summit Therapeutics has 797.75 million SMMT shares outstanding. Investors often track the SMMT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SMMT share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 11/11/2020.
| SMMT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
SMMT Historical Shares Outstanding: +49.19% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| SMMT Stock Price Chart |
| About Summit Therapeutics Inc |
| Summit Therapeutics is holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicinal therapies. Co.'s ivonescimab is a bispecific antibody that combines the benefits of immunotherapy via a blockade of PD-1 with the anti-angiogenesis benefits of an anti-vascular endothelial growth factor into a single molecule. Co. also focuses on ridinilazole, its product candidate for treating patients suffering from Clostridioides difficile infection. Co.'s other product candidate, SMT-738, is in development for combating multidrug resistant infections, specifically carbapenem-resistant Enterobacteriaceae infections. We show 21 historical shares outstanding datapoints in our coverage of SMMT's shares outstanding history. Understanding the changing numbers of SMMT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SMMT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SMMT by allowing them to research SMMT shares outstanding history as well as any other stock in our coverage universe. |
| SMMT Current Stock Quote |
Quotes delayed 20 minutes  Free SMMT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SMMT Share Performance |
| Shares Outstanding Peers |
| Summit Therapeutics (SMMT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SMTI Shares Outstanding History SNBP Shares Outstanding History SNCA Shares Outstanding History SNDA Shares Outstanding History SNDX Shares Outstanding History SNES Shares Outstanding History SNGX Shares Outstanding History SNNA Shares Outstanding History SNOA Shares Outstanding History SNPX Shares Outstanding History More Healthcare companies » |
SMMT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
